Koppert Biological Systems India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -32.76%
(FY 2022)
- Profit -788.59%
(FY 2022)
- Ebitda -157.07%
(FY 2022)
- Net Worth -45.00%
(FY 2022)
- Total Assets -43.51%
(FY 2022)
About Koppert Biological Systems India
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hendrik Paul, Paulus Koppert, and Bhat Udayanarayan serve as directors at the Company.
- CIN/LLPIN
U01403KA2012FTC065033
- Company No.
065033
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
26 Jul 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Koppert Biological Systems India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhat Udayanarayan  | Whole-Time Director | 22-Nov-2013 | Current |
Hendrik Paul  | Nominee Director | 26-Jul-2012 | Current |
| Paulus Koppert | Nominee Director | 26-Jul-2012 | Current |
Financial Performance and Corporate Structure Insights of Koppert Biological Systems India.
Koppert Biological Systems India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 32.76% decrease. The company also saw a substantial fall in profitability, with a 788.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Koppert Biological Systems India?
In 2022, Koppert Biological Systems India had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Koppert Sustainable Solutions (India) Private LimitedActive 29 years 7 monthsHendrik Paul and Bhat Udayanarayan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Koppert Biological Systems India?
Koppert Biological Systems India has a workforce of 38 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Koppert Biological Systems India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Koppert Biological Systems India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
